M Neuss,C Butter
M Neuss
Several multicenter randomized clinical trials have established cardiac resynchronization as a safe and effective way to treat heart failure patients. This is reflected in the Focus Update of the European guidelines that describes a class I...
H-H Minden
H-H Minden
Coronary sinus (CS) lead positioning is one of the main determinants of cardiac resynchronization therapy (CRT). The implantation of the CS lead is faced with several technical difficulties that may prevent the achievement of a stable posit...
[Cardiac resynchronization in narrow QRS and less affected exercise capacity] [0.03%]
窄QRS波群及运动能力降低时的再同步化治疗
M Stockburger
M Stockburger
Cardiac resynchronization (CRT) through atrio-biventricular pacemaker therapy is now a well established treatment option for severely symptomatic patients with advanced systolic heart failure (HF) and intraventricular conduction delay, espe...
Visualization of multiple catheters in left atrial ablation procedures. Comparison of two different 3D mapping systems [0.03%]
左心房射频消融手术中导管的三维可视化及两种不同三维电解剖导航系统比较研究
C Jilek,G Hessling,S Ammar et al.
C Jilek et al.
Background: Visualization of intracardiac catheters placed in predefined anatomic locations is a cornerstone for successful atrial fibrillation (AF) ablation. The 3D mapping system Carto3™ (Biosense Webster, Diamond Bar,...
C Jabbour,E-M Oenning,J Neuzner et al.
C Jabbour et al.
In patients with hypertrophic cardiomyopathy (HOCM), the decision for an implantable cardioverter-defibrillator (ICD) depends highly on the exact identification of the etiology of syncope. In this article, the case of a patient with HOCM an...
[Catheter ablation of premature ventricular complexes in a patient with progressive heart failure] [0.03%]
[进行性心力衰竭患者的早发性室性复合窦搏的导管消融术]
C Meyer,M Martinek,J Aichinger et al.
C Meyer et al.
Ischemic heart disease is characterized by hemodynamic adaptations and an increased risk of ventricular arrhythmias. Frequent premature ventricular complexes (PVCs) have been associated with ventricular reentry arrhythmias and can promote t...
[Class I antiarrhythmic drugs: mechanisms, contraindications, and current indications] [0.03%]
[I类抗心律失常药物：机制、禁忌症及目前适应证]
C Pott,D G Dechering,A Muszynski et al.
C Pott et al.
Class I antiarrhythmic drugs are sodium channel inhibitors that act by slowing myocardial conduction and, thus, interrupting or preventing reentrant arrhythmia. Due to proarrhythmic effects and the risk of ventricular tachyarrhythmia, class...
H Simon,K Simon Demel,G Ritscher et al.
H Simon et al.
Atrial fibrillation, which is associated with a worsening of congestive heart failure symptoms, an increased rate of stoke, and increased mortality, is still difficult to treat. New therapies must not only increase effectiveness, but also h...
B-D Gonska,U Ravens
B-D Gonska
G C Grönefeld,D Bänsch
G C Grönefeld
β-Blockers are an essential component of medical therapy in patients with ischemic heart disease or cardiac dysfunction of any genesis. They have an effect at the level of the sinus and the atrioventricular node, as well as on the atrial a...